Reaction
Obstruction Gastric reporting signals
As of the last recalculation, Obstruction Gastric appears in 1,249 FAERS reports alongside 19 co-occurring drug terms. The strongest observed disproportionality signal is LEUCOVORIN CALCIUM (PRR 15.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Leucovorin Calcium | 18 | 15.9 | 15.9 |
| Gemcitabine | 33 | 14.3 | 14.3 |
| Erythromycin | 15 | 13.5 | 13.5 |
| Gemcitabine Hydrochloride | 41 | 13.3 | 13.3 |
| Irinotecan Hydrochloride | 10 | 13.1 | 13.1 |
| Dronabinol | 6 | 12.5 | 12.5 |
| Pancrelipase | 28 | 12.3 | 12.4 |
| Erlotinib | 7 | 12.1 | 12.1 |
| Erlotinib Hydrochloride | 9 | 12.1 | 12.1 |
| Sitagliptin And Metformin Hydrochloride | 14 | 10.9 | 10.9 |
| Capecitabine | 53 | 10.0 | 10.0 |
| Oxaliplatin | 37 | 8.5 | 8.5 |
| Fam-Trastuzumab Deruxtecan-Nxki | 5 | 8.3 | 8.3 |
| Trifluridine And Tipiracil | 5 | 7.8 | 7.8 |
| Loratadine And Pseudoephedrine Sulfate | 3 | 6.3 | 6.3 |
| Acetaminophen, Aspirin (Nsaid) And Caffeine | 6 | 5.9 | 5.9 |
| Rucaparib | 3 | 5.7 | 5.7 |
| Oral Semaglutide | 23 | 5.3 | 5.3 |
| Atezolizumab | 12 | 5.2 | 5.2 |